IOVS Hypertension
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2007;48:4328-4334.)
© 2007 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.06-1148

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koto, T.
Right arrow Articles by Ishida, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koto, T.
Right arrow Articles by Ishida, S.

Eicosapentaenoic Acid Is Anti-Inflammatory in Preventing Choroidal Neovascularization in Mice

Takashi Koto,1,2 Norihiro Nagai,1,2 Hiroshi Mochimaru,1,2 Toshihide Kurihara,1,2 Kanako Izumi-Nagai,1,2 Shingo Satofuka,1,2 Hajime Shinoda,1,2 Kousuke Noda,2 Yoko Ozawa,1,2 Makoto Inoue,2 Kazuo Tsubota,2 Yuichi Oike,1,3 and Susumu Ishida1,2

1From the Laboratory of Retinal Cell Biology, the 2Department of Ophthalmology, and the 3Laboratory of Vascular Biology and Metabolism, Keio University School of Medicine, Tokyo, Japan.

PURPOSE. To investigate the role of eicosapentaenoic acid (EPA), the major {omega}-3 polyunsaturated fatty acid (PUFA), in the development of choroidal neovascularization (CNV), together with underlying molecular mechanisms.

METHODS. Six-week-old C57BL/6 mice were fed with laboratory chow with 5% EPA or the {omega}-6 PUFA linoleic acid (LA) for 4 weeks. Laser photocoagulation was performed to induce CNV, and the volume of CNV tissue was evaluated by volumetric measurements. The expression and production of intercellular adhesion molecule (ICAM)-1, monocyte chemotactic protein (MCP)-1, vascular endothelial growth factor (VEGF) and interleukin (IL)-6 in the retinal pigment epithelium (RPE)-choroid in vivo, and stimulated b-End3 endothelial cells and RAW264.7 macrophages in vitro were evaluated by RT-PCR and ELISA. Fatty acid composition in the serum and the RPE-choroid was analyzed by gas chromatography and high-performance liquid chromatography, respectively. Serum levels of C-reactive protein (CRP), IL-6, VEGF, MCP-1, and soluble ICAM-1 were examined by ELISA.

RESULTS. The CNV volume in EPA-fed animals was significantly suppressed compared with that in control mice, whereas the LA-rich diet did not affect CNV. The mRNA expression and protein levels of ICAM-1, MCP-1, VEGF, and IL-6 after CNV induction were significantly reduced in EPA-supplemented mice. In vitro, EPA application led to significant inhibition of mRNA and protein levels of ICAM-1 and MCP-1 in endothelial cells and VEGF and IL-6 in macrophages. EPA-fed mice exhibited significantly higher levels of EPA and lower levels of the {omega}-6 PUFA arachidonic acid in the serum and the RPE-choroid than control animals. EPA supplementation also led to significant reduction of serum levels of IL-6 and CRP after CNV induction.

CONCLUSIONS. The present study demonstrates for the first time that an EPA-rich diet results in significant suppression of CNV and CNV-related inflammatory molecules in vivo and in vitro. These results suggest that frequent consumption of {omega}-3 PUFAs may prevent CNV and lower the risk of blindness due to age-related macular degeneration.





This article has been cited by other articles:


Home page
Arch OphthalmolHome page
J. P. SanGiovanni, E. Agron, T. E. Clemons, and E. Y. Chew
{omega}-3 Long-Chain Polyunsaturated Fatty Acid Intake Inversely Associated With 12-Year Progression to Advanced Age-Related Macular Degeneration
Arch Ophthalmol, January 1, 2009; 127(1): 110 - 112.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Yamada, M. Yoshida, Y. Nakano, T. Suganami, N. Satoh, T. Mita, K. Azuma, M. Itoh, Y. Yamamoto, Y. Kamei, et al.
In Vivo and In Vitro Inhibition of Monocyte Adhesion to Endothelial Cells and Endothelial Adhesion Molecules by Eicosapentaenoic Acid
Arterioscler. Thromb. Vasc. Biol., December 1, 2008; 28(12): 2173 - 2179.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
J. P. SanGiovanni, E. Y. Chew, E. Agron, T. E. Clemons, F. L. Ferris III, G. Gensler, A. S. Lindblad, R. C. Milton, J. M. Seddon, R. Klein, et al.
The Relationship of Dietary {omega}-3 Long-Chain Polyunsaturated Fatty Acid Intake With Incident Age-Related Macular Degeneration: AREDS Report No. 23
Arch Ophthalmol, September 1, 2008; 126(9): 1274 - 1279.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
N. Farag, A. N. Ship, and J. G. Arroyo
Update: A 76-Year-Old Man With Macular Degeneration
JAMA, July 2, 2008; 300(1): 91 - 92.
[Full Text] [PDF]


Home page
Arch OphthalmolHome page
E. W-T. Chong, A. J. Kreis, T. Y. Wong, J. A. Simpson, and R. H. Guymer
Dietary {omega}-3 Fatty Acid and Fish Intake in the Primary Prevention of Age-Related Macular Degeneration: A Systematic Review and Meta-analysis
Arch Ophthalmol, June 1, 2008; 126(6): 826 - 833.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Association for Research in Vision and Ophthalmology